Introduction
Nitric oxide (NO), a versatile second messenger, aects numerous physiological functions. NO, produced in the organism by a family of NO synthases (NOS), has been implicated in the regulation of blood pressure, immunity, and neurotransmission (Bredt and Snyder, 1994; Nathan and Xie, 1994; Stamler, 1994; Garthwaite and Boulton, 1995) . It is also critically involved in many pathological responses, such as in¯ammation, septic shock, and neurotoxicity (Gross and Wolin, 1995; Nicotera et al., 1999; Lipton, 1999) . Furthermore, NO can aect cell division, programmed cell death, or acquisition of dierentiated phenotype (Peunova and Enikolopov, 1995; Kuzin et al., 1996; Enikolopov et al., 1999; Papapetropoulos et al., 1997; Poluha et al., 1997; Ishida et al., 1997; Mannick et al., 1997; Forrester et al., 1996; Messmer and Brune, 1996; Brune et al., 1998; Gibbs and Truman, 1998; Wingrove and O'Farrell, 1999) .
Some of the long lasting eects of NO may be related to its ability to act as a potent regulator of proliferation: exogenously added NO can reversibly suppress DNA synthesis and progression through the various phases of the cell cycle (Stamler, 1994; Garg and Hassid, 1990; Lepoivre et al., 1990; Kwon et al., 1991) , and can induce or suppress programmed cell death in particular cell types (Nicotera et al., 1999; Lipton, 1999; Mannick et al., 1997; Brune et al., 1998) . It has been further speculated that part of the action of NO as a signaling molecule re¯ects its highly reactive nature and its potential, at high concentrations, to modify and damage DNA Tamir et al., 1996) ; however, the relevance of this feature of NO to its action in vivo is still unclear. The ability of NO to aect both cell proliferation and cell death resembles the properties of the key tumor suppressor protein p53, and, indeed, it has been shown that NO can strongly induce p53 in several settings (Forrester et al., 1996; Messmer and Brune, 1996; Brune et al., 1998) .
Whereas the short-term NO-induced signaling pathways are well characterized, the signaling cascades that mediate long-term changes induced by NO are poorly understood. For instance, we know neither the range of protein kinases activated by NO, nor their substrates. Furthermore, even the gene targets of NO remain uncharacterized. One approach to unraveling mechanisms of long-term action of NO is to characterize the changes and establish the signature of exposure to NO: de®ne sets of activated genes, activated protein kinases, changes in phosphorylation status of key regulatory molecules, etc., and compare them to other, well characterized, signaling cascades. An extensive overlap between the tell-tale signatures of dierent inducers may point to commonalties in the signaling pathways mediating their action.
Here we show that part of the antiproliferative action of NO in ®broblasts is mediated by p53, such that p53-de®cient cells are compromised in their ability to stop dividing in response to NO. We also show that NO induces a set of p53-dependent genes and leads to a steady increase in the amount of p53 protein. Since the activity of p53 often correlates with site-speci®c modi®cations of the p53 molecule, we compared the changes in p53 induced both by NO and by other known activators of p53. We found that NO induces a speci®c signature pattern of p53 phosphorylation, distinct from the patterns evoked by other inducers. Our results indicate that NO activates multiple signaling pathways and may regulate changes in cell physiology via changes in gene expression and speci®c modi®cations of the key regulatory protein p53.
Results

A subset of NO-inducible genes is dependent on p53
NO induces changes in gene expression To examine signaling pathways which may determine the antiproliferative activity of NO, we started by searching for the gene targets of NO. We used cDNA expression arrays (Atlas mouse cDNA array, Clontech) to study the NO-induced changes in the transcription of 588 known genes in NIH3T3 mouse ®broblasts. We compared RNA from control cells and from cells treated with chemical compounds which generate NO upon hydrolysis. To ensure that the observed changes were speci®cally due to the action of NO and were not caused by the byproducts of hydrolysis, we used three structurally distinct donors of NO whose pharmacological properties are well characterized ± S-nitroso-Nacetyl-D,L-penicillamine (SNAP), 1-hydroxy-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene (NOC12), and DETA NONOate (NOC18) in a vehicle of 0.05% dimethylsulfoxide (DMSO) (for review see Stamler and Feelisch, 1996) . Each of these compounds produces NO and dier from each other both by the kinetics of NO release and by the resulting products of hydrolysis. Since we were particularly interested in the antiproliferative eects of NO, we used NO donors at concentrations just above the minimum required to achieve complete cell cycle arrest of NIH3T3 cells (data not shown): 250 mM SNAP, 500 mM NOC12 and 250 mM NOC18. The compounds were not toxic to the cells at these concentrations, as judged both by the cells' viability after prolonged exposure to these compounds and by their ability to resume proliferation once the source of NO was removed (data not shown).
Cells were incubated with SNAP, NOC12, NOC18, or vehicle alone as a control for 16 h. Total RNA was isolated, and radioactive cDNA probes were prepared and hybridized with cDNA arrays. The results of hybridization experiments with cDNA arrays, validated by Northern blot analysis, show that treatment with each of the NO donors can strongly increase or decrease transcript levels of a number of tested genes ( Figure 1a ,b and data not shown). Essentially identical groups of genes were induced after exposure to each of the NO donors (albeit quantitatively to dierent extents), suggesting that the observed changes are due speci®cally to the action of NO.
Importantly, many of the genes that are up-regulated by NO are also known to be up-regulated by tumor suppressor p53 (Polyak et al., 1997; Madden et al., 1997; El-Deiry, 1998) . These genes include mdm2, gadd45, cyclin G, cyclin D1, egr-1, p21, c-myc, bax, and others (Figure 1a,b) . To test whether NO-induced transcriptional activation of some of the p53-inducible genes is indeed dependent on p53 and to ®nd which of the other NO-inducible genes are dependent on p53 for their activation, we used genetically modi®ed mice which are de®cient in the p53 gene (Jacks et al., 1994) . Figure 2 shows results of Northern blot analysis of RNA isolated from murine embryonic ®broblasts (MEFs) from p537/7 knock-out mice before and after stimulation with NO donor SNAP. When p537/7 cells were incubated with SNAP, the levels of mdm2, gadd45, cyclinG, bax, and TTF-1 transcripts (7) or with NO donor (+) were separated on a denaturing gel, transferred to the nylon membrane, and hybridized with radiolabeled probes Figure 2 Northern blot analysis of gene activation by NO donor SNAP in MEFs from p53-de®cient mice. Ten micrograms of total RNA from cells treated with 0.05% DMSO (7) or with NO donor (+) were separated on a denaturing gel, transferred to the nylon membrane, and hybridized with radiolabeled probes remained unaltered, suggesting that they are indeed activated by NO in a p53-dependent manner. In contrast, NO-dependent accumulation of transcripts of egr-1, MCP3, and ornithine decarboxylase (ODC) was not changed in p53-de®cient cells, suggesting that they do not require p53 for activation by NO. Interestingly, for two of these genes, egr-1 and ODC, transcripts are known to accumulate following increases in p53 protein level caused by other circumstances (Polyak et al., 1997; Madden et al., 1997; ElDeiry, 1998) , suggesting that their activation by NO and by p53 may proceed through dierent signal transduction pathways. Together, these experiments show that p53 is necessary for some but not all of the transcription activation eects of NO.
p53 mediates NO-induced cell cycle arrest Our results indicate that NO has a potent eect on the level of p53-dependent genes, perhaps by activating their transcription. Since many of the transcriptional targets of p53 are involved in cell cycle control and some (e.g., p21 and gadd45) can suppress cell division, this suggests that part of the antiproliferative activity of NO may be mediated by a p53-dependent pathway.
To determine whether the action of p53 was indeed required for NO-dependent cell cycle arrest, we studied proliferation of MEFs from wild-type and p53-de®cient knock-out mice in the presence and absence of the NO donor SNAP. Figure 3 shows that proliferation of wild-type MEFs was completely suppressed by incubation with 250 mM SNAP. In contrast, proliferation of p537/7 cells was only partially suppressed by SNAP. This suggests that a p53-dependent component contributes to the NO-induced cell cycle arrest, such that its removal partially limits the ability of NO to halt cell division. Together with the data on p53-dependent transcriptional targets of NO, these results suggest that NO utilizes p53-dependent signal transduction pathways to establish cell cycle arrest in ®broblasts.
NO increases the level of p53 In most of the studied systems, the ability of p53 to induce gene activity and suppress cell division is related to an increase in the level of p53 in the cell. p53 levels are elevated following gamma irradiation, UV irradiation, treatment with chemotherapeutic agents, and nucleotide depletion; this elevation usually re¯ects an increased stability of the protein (Levine, 1997; Prives, 1998; Giaccia and Kastan, 1998) . We asked whether treatment of NIH3T3 cells with the NO donor SNAP leads to elevated levels of p53 and compared the changes upon exposure to SNAP to the changes induced by treatment with gamma-irradiation, UV irradiation and a chemotherapeutic drug adriamycin. Figure 4a ,b shows that all four types of treatment increased the intracellular levels of p53 as assayed by Western blot. SNAP was as eective as gamma-or UV-irradiation or adriamycin treatment in increasing the level of p53. However, the kinetics of p53 induction was quite dierent for each of the inducers. Gamma irradiation of cells leads to a rapid increase of the levels of p53 protein, with a peak at 1 h followed by a rapid decline. The UV irradiationinduced increase of p53 was maximal at 4 h and was strongly diminished by 6 h. The adriamycin-induced increase of p53 was highest at 2 ± 3 h after application of the drug and slowly decreased over the course of the next 9 h. In contrast, treatment with SNAP induced a slow but steady increase of the amount of p53, which was maximal at 8 h after application of SNAP and sustained at nearly the same level for the next 4 h. These data demonstrate that incubation of cells with an NO donor leads to an increase in the level of p53 protein. The level of induction is comparable with the levels attained after treatment with other known inducers of p53, although the kinetics of induction was distinct for each of the inducers.
NO induces a speci®c pattern of phosphorylation of p53 Our results suggest that NO utilizes p53-dependent signal transduction pathways to activate a number of target genes. Increased levels of p53 protein and induction of p53 activity often correlates with sitespeci®c phosphorylation of the protein. Modi®cations of particular residues of p53 have been ascribed to activation of speci®c signaling pathways by gamma irradiation, UV irradiation, or treatment with chemotherapeutic agents (Levine, 1997; Prives, 1998; Giaccia and Kastan, 1998) . We decided to compare the pattern of appearance of phosphorylation at three residues of the p53 molecule after treatment with NO donors to the patterns of phosphorylation obtained after exposure to gamma-and UV-irradiation and adriamycin and to use these patterns as signatures to gain insights into the signaling pathways activated by NO. Identical or strongly overlapping patterns of p53 phosphorylation after exposure to various inducers could indicate that the signaling patterns activated by these inducers are similar, or might employ shared components. Conversely, highly dissimilar patterns of p53 phosphorylation could point to dissimilarities between the signaling pathways activated by these inducers. To study the signature patterns of p53 phosphorylation, we used a series of polyclonal antibodies which recognize phosphorylated sites on the p53 molecule and which do not react with the identical but unphosphorylated sites (Shieh et al., 1997; Siliciano et al., 1997; Canman et al., 1998) .
We tested the phosphorylation status of Ser18, Ser373 and Ser389 residues of mouse p53 (corresponding to Ser15, Ser376 and Ser392 residues in human p53). These residues are located in critical domains of the p53 molecule (Ser18 in the transcriptional activation domain, Ser373 and Ser392 in the carboxy-terminal domain which is important for allosteric regulation and oligomerization). Each of these residues have been shown to undergo speci®c phosphorylation by protein kinases in vitro and in vivo; these modi®cations in vivo correlate with an increase in the cellular level of p53, and are important for interaction with protein partners of p53, e.g., mdm2 and 14-3-3s (see Prives, 1998; Giaccia and Kastan, 1998 for review).
NIH3T3 cells were treated with SNAP, gammairradiation, UV-irradiation, or adriamycin for 30 min, 3 h, or 8 h. p53 protein was immunoprecipitated from the cell lysate using a high anity anti-p53 antibody pAb246, separated by electrophoresis on a polyacrylamide gel and transferred to a membrane. The Western blot was probed with antibodies which speci®cally recognize phosphorylated forms of Ser18, Ser373 and Ser389. Figure 5a shows that all four types of A B C Figure 5 Phosphorylation of speci®c residues of p53 protein after treatment with SNAP, gamma-irradiation, UV light, and adriamycin. (a) NIH3T3 cells were exposed to SNAP (250 mM), gamma-irradiation (10 Gy), UV-irradiation (40 J/m 2 ), or adriamycin (0.1 mg/ml), and cell lysates were prepared after 30 min, 3 h, and 8 h. p53 was immunoprecipitated from cell lysates using monoclonal anti-p53 antibody PAb246, separated in polyacrylamide gel and transferred to the membrane. Speci®c phosphorylated residues were detected using speci®c polyclonal antibodies directed against phosphorylated forms of Ser18, Ser372, and Ser389. (b) Immunoprecipitated samples were treated with 4 units of calf intestine alkaline phosphatase (CIP) before Western blotting was performed. (c) Schematic presentation of the changes in the phosphorylation pattern of p53 molecule treatment increased the intracellular levels of p53 as assayed by Western blot. Exposure to SNAP was as eective as other treatments in increasing the level of p53; however, the kinetics of p53 induction was dierent for each of the inducers. Furthermore, data in Figure 5a demonstrate that treatment with the NO donor SNAP, as well as exposure to other treatments (gamma-, UV-irradiation, adriamycin) leads to phosphorylation of these residues in the p53 molecule. The signals on the Western blot were speci®c to the phosphorylated forms of p53 and were completely abolished if cell lysates were treated with phosphatase before immunoprecipitation (Figure 5b) .
The results of the experiments in Figure 5a show that the temporal pattern of the appearance of phosphorylated residues on p53 after exposure to the NO donor SNAP is highly speci®c and does not resemble any of the phosphorylation patterns induced by other treatments: gamma-and UV-irradiation and adriamycin. The changes in the phosphorylation patterns are schematically summarized in Figure 5c . The residue Ser18 was phosphorylated very soon (30 min) after exposure to the NO donor and the signal was even stronger after 3 and 8 h. It was also strongly phosphorylated when cells were treated for 30 min with gamma-irradiation and UV-irradiation, and remained phosphorylated even after 8 h. In contrast, adriamycin hardly aected phosphorylation of Ser18 after 30 min, even though Ser18 was markedly phosphorylated 3 and 8 h post-treatment.
Phosphorylation of Ser373 was strongly induced after 30 min exposure to SNAP, remained constant at 3 h, and returned to the control levels after 8 h. In contrast, the phosphorylation status of Ser373 was not aected after exposure to UV-irradiation and adriamycin for 30 min, 3 h, or 8 h, whereas this residue was rapidly dephosphorylated after treatment with gammairradiation, in accordance with a previous report (Waterman et al., 1998) .
Finally, there was no increase in phosphorylation of Ser389 after 30 min of treatment with SNAP, but phosphorylation of this residue was detected after 3 h and the residue remained phosphorylated up to 8 h after treatment. UV-irradiation, however, induced an increase in phosphorylation of Ser389 after 30 min. Phosphorylation levels were high after 3 h of exposure to UV light and returned to the background steadystate levels after 8 h. A very similar pattern of phosphorylation of Ser389 was seen when cells were treated with adriamycin. In contrast, gamma irradiation of cells induced a very rapid phosphorylation of the residue (strong signal after 30 min), as described previously, but it returned to the initial levels by 3 h and remained there at 8 h. Together, these data demonstrate that the NO donor SNAP induces phosphorylation of Ser18, Ser373 and Ser389, and that the temporal pattern of changes induced by SNAP is dierent from the changes induced by other agents acting on p53. This suggests that the signaling pathways activated by these agents may be dierent as well.
Discussion
NO is a very eective inhibitor of cell proliferation, reversibly suppressing DNA synthesis and cell division.
In this study we have demonstrated that part of the antiproliferative activity of NO in ®broblasts is mediated by p53 and/or p53-dependent genes, and that NO induces a unique temporal signature pattern of phosphorylation at three residues of the p53 molecule. The ®nding that absence of p53 gene interferes with the ability of NO to induce cell cycle arrest in MEFs (Figure 3 ), corresponds well with the ability of p53 to prevent cell division. At the same time, our data suggest that NO also uses other, nonp53-dependent pathways to induce cell cycle arrest, since proliferation of p537/7 MEFs was still partially impaired in the presence of NO.
The hypothesis that NO employs the p53 pathway to induce cell cycle arrest in NIH3T3 cells is supported by the observed increases in the level of p53 protein following the exposure to NO (Figure 4 ) and the concomitant increase in the levels of RNA of several p53 target genes (Figures 1 and 2) . Among the p53 targets is the cyclin-dependent kinase (cdk) inhibitor p21WAF1, whose promoter contains strong p53-binding sites. p21 binds to and inhibits cdks and thus blocks G1/S transition in the cell cycle. Its transcription is strongly induced by NO in NIH3T3 cells but not in p537/7 MEFs (Figures 1 and 2 ), in line with observations that NO induces transcription of p21 in several cell types (Polyak et al., 1997; Madden et al., 1997; El-Deiry, 1998 ). Thus, it is possible that some of the antiproliferative activity of NO is explained by suppression of G1/S transition via induction of p21 in a p53-dependent manner. At the same time, NO may be capable of aecting cell cycle control at other critical points. This may include S phase, since NO is a potent inhibitor of ribonucleotide reductase (Lepoivre et al., 1990; Kwon et al., 1991) , a rate limiting component of DNA synthesis. Furthermore, it may include G2 phase, perhaps via p53 and 14-3-3s protein whose interaction with p53 may be modulated by the phosphorylation status of Ser373 residue of p53 (Waterman et al., 1998) ; we also note that NO induces 14-3-3s RNA in NIH3T3 cells (Nakaya et al., unpublished observations).
The idea that p53 is an important mediator of the antiproliferative activity of NO is in agreement with our observation that the level of p53 protein is strongly increased after treatment with NO donors. It is known that p53 is stabilized through post-translational mechanisms in response to stress, DNA damage, hypoxia, and nucleotide depletion, leading to cell cycle arrest or to apoptotic cell death (Levine, 1997; Prives, 1998; Giaccia and Kastan, 1998) . This is also seen in response to NO: for example, NO donors activate p53 and elicit rapid apoptosis in macrophage RAW cells (Messmer and Brune, 1996; Brune et al., 1998) . In our experiments, where exposure to NO results in cell cycle arrest, NO similarly acts as a potent inducer of p53 accumulation, with levels of p53 after exposure to NO donors comparable to those induced by gamma-and UV-irradiation and adriamycin (note, however, that the time course of p53 accumulation after exposure to NO donors was very dierent from that seen after irradiation or drug treatment).
Since NO can modify and damage DNA at high concentrations (for instance, when produced through sustained activity of NOS2 or by high levels of NOreleasing compounds), it may activate the same signaling pathways that lead to p53 activation after gamma-and UV-irradiation and chemotherapeutic drugs, treatments that damage the integrity of DNA. However, it is also possible that the response to NO may not be simply equivalent to the response to DNA damage induced by irradiation and drugs, but that NO may employ dierent signaling pathways than these other activators of p53. We explored this possibility by studying the temporal signature phosphorylation of the p53 molecule. We found that the residues phosphorylated in response to NO exposure were also phosphorylated in response to gamma irradiation, ultraviolet light, and adriamycin. At the same time we found that the kinetics and the overall temporal pattern of NO-induced phosphorylation of p53 are unique and do not mimic the temporal signature of the other inducers.
For instance, phosphorylation of the Ser18 residue (Ser15 in human p53; a target for various protein kinases in vivo and in vitro, including the ataxiatelangectasia mutated (ATM) kinase), results in a lowered anity of p53 for mdm2, an increased half life time of p53 protein, and an increase in the activity of p53 as a transcription factor (Shieh et al., 1997; Siliciano et al., 1997) . Ser18 is rapidly phosphorylated by exposure to SNAP, gamma-irradiation, and UVirradiation, but not adriamycin, whose eect on Ser18 can be seen only later. At the same time, phosphorylation of Ser389 (Ser392 in human p53; a target for caseine kinase II in vitro) is induced by UV-irradiation and adriamycin after 30 min, reaches high levels after 3 h and decreases to the background levels after 8 h. Gamma irradiation induces very rapid phosphorylation of this residue at 30 min which completely disappears after 3 h. In contrast to both of these modes, SNAP does not change the phosphorylation status of Ser389 after 30 min, but leads to delayed but marked phosphorylation after 3 h, which is maintained after 8 h of exposure to SNAP. Finally, the phosphorylation status of the Ser373 diers even more between these types of treatments. This residue (Ser376 in human p53; a target for protein kinase C in vitro) is maintained in phosphorylated form in uninduced MCF-7 cells, but has been reported to be rapidly dephosphorylated after exposure to gamma irradiation (Waterman et al., 1998) . In our experiments, neither UV light nor adriamycin noticeably changed the phosphorylation status of Ser373. However, treatment with gamma irradiation resulted in a rapid decrease in phosphorylation of this residue after 30 min, whereas exposure to SNAP resulted in a strong and rapid increase of phosphorylation.
Thus, each type of treatment induces a unique pattern of modi®cation of p53 molecule. This suggests that NO, when activating gene expression and inducing cell cycle arrest, activates speci®c signal transduction pathways, which may share common elements with pathways activated by other inducers of p53. However, these NO-activated pathways are not identical to those activated by DNA-damaging agents. Each of the three phosphorylation sites in p53 are targets for distinct protein kinases (ATM, PKC, casein kinase II), suggesting that modi®cations of the p53 molecule after exposure to NO are mediated by several dierent signaling cascades. Thus, a unique combination of signaling cascades is employed by NO as it eects long lasting changes in cell physiology.
Materials and methods
RNA preparation, hybridization with cDNA arrays, and Northern blotting NIH3T3 cells were treated with three dierent NO-donors: 7S-nitroso-N-acetyl-D,L-penicillamine (SNAP); 1-hydroxy-2-oxo-3-(N-ethyl-2-aminoethyl)-3-ethyl-1-triazene (NOC12) and DETA NONOate (NOC18) or with 0.05% dimethylsulfoxide (DMSO; used as a vehicle for NO donors) for 16 h. Total RNA was extracted from cells by acidic guanidiumthiocyanate-phenol-chloroform mixture using Triazol (GIB-CO BRL, NY, USA). One hundred mg of total RNA from each sample was used for the puri®cation of polyA + RNA by Oligotex (QIAGEN, CA, USA). One mg of polyA + RNA was used for synthesizing cDNA probe labeled with 33 P-dATP (Amersham). Atlase mouse cDNA expression array membranes (Clontech, CA, USA) were prehybridized with 10 ml hybridization buer, including 0.05 M sodium phosphate, pH 7.0, 56SSC, 46Denhardt's solution, 1% SDS, 50% formamide, 0.1 mg/ml sheared salmon sperm DNA and 0.2 mg/ml yeast RNA, at 568C for 6 h. The solution was changed to 5 ml hybridization buer containing 5610 6 c.p.m. of labeled cDNA probe and the incubation was continued at 568C for another 18 h. The membranes were washed once with 26SSC with 0.1% SDS at room temperature for 5 min, once with 0.16SSC with 0.1% SDS at 568C for 5 min and once with 16SSC at room temperature for 5 min. The membranes were contacted with an imaging plate and the data was analysed on the BAX100 imaging analyser (Fuji, Japan).
For Northern blotting 10 mg of total RNA from cells treated with NO-donors was separated by denaturing formaldehyde-agarose gel electrophoresis. RNA was transferred from the gel to the nylon membrane (Hybond N+, Amersham) by capillary blotting. Speci®c probes were labeled with 32 P-dCTP (Amersham) by the random primer method and hybridization and washing were performed as described for cDNA arrays. The membranes were exposed for 3 days at 7808C using Kodak X-OMAT X-ray ®lm (Kodak, NY, USA).
Western blot analysis and immunoprecipitation
NIH3T3 cells were exposed to 250 mM SNAP, 10 Gy of gamma irradiation using MarkII cesium-137 irradiator, 40 J/m 2 of UV irradiation using transilluminator, or 0.1 mg/ ml of adriamycin (Sigma). Cells were harvested on ice and suspended in 0.2 ml of lysis buer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 400 mM NaCl, 10% Glycerol, 0.5% NP40, 5 mM NaF, 0.5 mM sodium orthovanadate, 1 mM DTT, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 1 mg/ml pepstatin) for 20 min. After spinning at 14 000 r.p.m. for 30 min, the supernatant was collected and 4 ml of sample were used for the determination of protein concentration using the BCA protein assay reagent (Pierce, IL, USA). Each sample, which was normalized for the amount of protein by diluting with lysis buer, was pretreated at 48C for 30 min with 15 ml of a 50% suspension of Protein G Sepharose (Pharmacia, Uppsala) which was blocked with 0.1% BSA. The supernatant was transferred to a tube containing 15 ml of Protein G Sepharose coupled with an anti-p53 antibody pAb246. After an overnight incubation at 48C, Protein G Sepharose was washed ®ve times with 200 ml of wash buer (10 mM Tris-HCl pH 7.5, 250 mM NaCl, 0.2% NP40, 0.1% Triton X-100, 0.01% SDS, 1 mM DTT, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 1 mg/ml pepstatin) and ®nally mixed with 40 ml of the sample buer (125 mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol, 0.01% bromphenol blue and 100 mM 2-mercaptoethanol). For treatment with calf intestine alkaline phosphatase (CIP), the Sepharose pellet was washed ®ve times and suspended in 20 ml of CIP reaction buer (50 mM Tris-HCl pH 7.9, 10 mM MgCl2, 100 mM NaCl, 1 mM DTT and 4 U CIP) and incubated at 308C for 30 min. Twenty ml of 26 sample buer was added to the reaction solution; the sample was boiled for 3 min and loaded onto the 10.5% SDS-polyacrilamide gel. Separated proteins were transferred from the gel to Immobilon P membrane (Millipore, MA, USA) by semi-dry blotting. The membrane was blocked with 5% dry milk in 0.02% Tween 20 in PBS (TBS) for 15 min and incubated in the same solution for 1 h at room temperature with primary antibodies: CM5 for p53, Ser18P for detecting the phosphorylated form of serine 18 residue of p53, Ser373P for the phosphorylated form of serine 373, and Ser389P for the phosphorylated form of serine 389. After washing three times with TBS, the membrane was incubated with anti-rabbit IgG antibody conjugated with horseradish peroxidase (HRP) at room temperature for 1 h. The membrane was washed three times with TBS and once with distilled water. Chemiluminescent substrate for HRP (Supersignal West Dura Extended Duration Substrate, Pierce, IL, USA) was added to the membrane and the signal was detected using Kodak X-OMAT X-ray ®lm.
